245620 — Eone Diagnomics Genome Center Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro Cap

Annual balance sheet for Eone Diagnomics Genome Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27,597	4,985	9,735	9,546	16,392
Net Total Accounts Receivable
Net Total Receivables	13,988	20,392	23,987	9,911	1,569
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	59,230	41,612	46,252	45,471	18,957
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	54,404	87,894	87,761	34,786	21,477
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	186,938	192,011	173,519	86,084	44,013
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	59,905	108,451	87,548	121,511	60,114
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	128,830	160,062	135,294	131,241	66,539
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	58,108	31,948	38,224	-45,157	-22,525
Total Liabilities & Shareholders' Equity	186,938	192,011	173,519	86,084	44,013
Total Common Shares Outstanding